Enduraphin, Inc.

Enduraphin, Inc. , based in the US, specializes in performance nutrition products, offering innovative solutions for athletes through its unique beverage formulations and effective nutritional support systems. Founded in 2018 and headquartered in Orlando, US, Enduraphin, Inc. focuses on advancing the landscape of performance nutrition.

The company was established by a team with prior entrepreneurial experience, seeking to innovate within the health and wellness sector. As of November 2025, Enduraphin has completed one funding deal, aligning its operations toward enhancing its product offerings. Enduraphin® provides a variety of performance nutrition products, including its Athletic Fuel whey protein and ready-to-mix beverages. The company utilizes patented, single-use, recyclable bottles with dual built-in PHINs, allowing for convenient preparation and consumption.

Their products address the nutritional needs of athletes and fitness enthusiasts, serving professional teams, universities, and individuals primarily in North America, especially in the US and Canada. Enduraphin’s offerings are integrated into the training regimens of sport organizations like the Arizona Coyotes and Clarkson University. Enduraphin generates revenue from direct-to-consumer sales, partnerships with athletic organizations, and retail distribution. Their individual ready-to-mix bottles and whey protein products are strategically priced to attract a wide range of customers from casual consumers to serious athletes.

Their flagship product, Athletic Fuel, is positioned as a premium offering, and by collaborating with fitness facilities and professional teams, Enduraphin builds recurring business relationships that enable bulk purchases. In November 2025, Enduraphin, Inc. raised an undisclosed amount of Seed funding from individual investors to support its product development initiatives. The company plans to launch new products designed specifically to enhance athletic performance and recovery, targeting expansion into additional geographic markets by 2026.

This funding will facilitate the development and marketing of these innovative product offerings, reinforcing Enduraphin's commitment to advancing performance nutrition.